VRTX

Trade Vertex Pharmaceuticals Incorporated - VRTX stock price

1m
5m
15m
30m
1H
4H
1D
1W
History

VRTX

Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI (lumacaftor in combination with ivacaftor) to treat patients with CF 12 years of age and older who are homozygous for the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; KALYDECO (ivacaftor) for the treatment of patients with CF who have specific mutations in their CFTR gene, including the G551D mutation; and SYMDEKO (tezacaftor in combination with ivacaftor) to treat patients with CF 12 years of age and older who are F508del homozygous or who have 1 mutation that is responsive to tezacaftor/ivacaftor. The company also develops VX-659 and VX-445, which are CFTR corrector compounds in Phase II clinical trial; VX-150 that is in Phase II clinical trial to treat pain; VX-128, which is in Phase I clinical trial for the treatment of pain; CTX001, an investigational gene editing treatment that is in Phase I/II trial for the treatment of beta-thalassemia and sickle cell disease; pimodivir (JNJ-63623872), which is in a Phase III clinical development program to treat influenza; and VX-210 to treat acute spinal cord injury. It sells its products primarily to specialty pharmacy providers in North America, as well as government-owned and supported customers internationally. The company has collaborations with Cystic Fibrosis Foundation Therapeutics Incorporated; CRISPR Therapeutics AG; Moderna Therapeutics, Inc.; BioAxone Biosciences, Inc.; Parion Sciences, Inc.; Merck KGaA; Janssen Pharmaceuticals, Inc; and Q-State Biosciences, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
White Paper Declaration
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

VRTX price history

Date Close Change Change(%) Open High Low
Jan 18, 2022 230.91 1.90 0.83% 229.01 231.97 228.48
Jan 14, 2022 233.77 7.35 3.25% 226.42 234.34 226.42
Jan 13, 2022 226.36 1.85 0.82% 224.51 227.95 224.50
Jan 12, 2022 225.98 1.15 0.51% 224.83 226.82 223.49
Jan 11, 2022 225.90 1.56 0.70% 224.34 226.63 222.00
Jan 10, 2022 223.77 1.31 0.59% 222.46 225.69 218.86
Jan 7, 2022 221.71 1.35 0.61% 220.36 223.75 219.86
Jan 6, 2022 221.50 -0.04 -0.02% 221.54 223.77 220.86
Jan 5, 2022 221.18 -0.86 -0.39% 222.04 224.74 220.55
Jan 4, 2022 221.64 3.48 1.60% 218.16 222.49 218.14
Jan 3, 2022 222.38 4.16 1.91% 218.22 222.41 214.50
Dec 31, 2021 219.44 -2.41 -1.09% 221.85 222.97 218.88
Dec 30, 2021 222.28 -0.36 -0.16% 222.64 224.32 221.85
Dec 29, 2021 223.06 2.05 0.93% 221.01 223.76 220.73
Dec 28, 2021 221.76 1.05 0.48% 220.71 222.85 220.04
Dec 27, 2021 222.12 -1.17 -0.52% 223.29 223.72 220.36
Dec 23, 2021 223.28 0.43 0.19% 222.85 224.15 221.24
Dec 22, 2021 222.61 4.75 2.18% 217.86 222.83 217.86
Dec 21, 2021 218.48 1.62 0.75% 216.86 218.61 215.36
Dec 20, 2021 215.26 0.03 0.01% 215.23 216.16 213.06